Genetron Holdings Ltd - ADR

NASDAQ:GTH  
13.51
-0.48 (-3.43%)
Earnings Announcements

Genetron Health Reports Third Quarter 2020 Unaudited Financial Results And Provides Business Update

Published: 11/09/2020 12:01 GMT
(GTH) - Genetron Health Reports Third Quarter 2020 Unaudited Financial Results and Provides Business Update.
Q3 Loss per Share $0.02.
Q3 Revenue Rose 37.6 Percent to Rmb 112 Million.
Q3 Loss per Share $0.01 Excluding Items.
In Early Screening for Liver Cancer, We Plan to Further Ramp Up Our Commercialization Initiatives in China.
Revenue is expected to be $19.9 Million
Adjusted EPS is expected to be -$0.06

Next Quarter Revenue Guidance is expected to be $20.21 Million
Next Quarter EPS Guidance is expected to be -$0.07

More details on our Analysts Page.